Xvivo Perfusion AB (publ)

DB:3XV Stock Report

Market Cap: €1.2b

Xvivo Perfusion Future Growth

Future criteria checks 5/6

Xvivo Perfusion is forecast to grow earnings and revenue by 26.3% and 29.4% per annum respectively. EPS is expected to grow by 25.9% per annum. Return on equity is forecast to be 11.4% in 3 years.

Key information

26.3%

Earnings growth rate

25.9%

EPS growth rate

Medical Equipment earnings growth14.2%
Revenue growth rate29.4%
Future return on equity11.4%
Analyst coverage

Good

Last updated22 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

DB:3XV - Analysts future estimates and past financials data (SEK Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20261,5253021504015
12/31/20251,138175-42446
12/31/202482512361785
9/30/2024751204-11867N/A
6/30/2024699121-10369N/A
3/31/2024643100-9360N/A
12/31/202359892-9846N/A
9/30/202357324-7250N/A
6/30/202352427-8642N/A
3/31/202346328-10825N/A
12/31/202241518-10328N/A
9/30/202237030-1276N/A
6/30/202232823-138-20N/A
3/31/20222937-138-32N/A
12/31/20212588-106-12N/A
9/30/2021233-24-116-33N/A
6/30/2021221-37-104-27N/A
3/31/2021192-44-79-11N/A
12/31/2020180-44-77-12N/A
9/30/2020182-26-683N/A
6/30/2020194-6-5420N/A
3/31/202022012-4939N/A
12/31/20192215-5430N/A
9/30/201921712-3734N/A
6/30/20192037-4223N/A
3/31/20191939-4115N/A
12/31/201818813-3124N/A
9/30/201817113-2134N/A
6/30/201816213N/A38N/A
3/31/201815310N/A33N/A
12/31/20171486N/A22N/A
9/30/20171450N/A8N/A
6/30/20171450N/A6N/A
3/31/20171420N/A5N/A
12/31/20161382N/A13N/A
9/30/20161325N/A22N/A
6/30/20161277N/A19N/A
3/31/20161226N/A20N/A
12/31/20151205N/A9N/A
9/30/20151134N/A-1N/A
6/30/20151094N/A1N/A
3/31/2015983N/A-7N/A
12/31/2014855N/A-5N/A
9/30/2014796N/A9N/A
6/30/2014747N/A3N/A
3/31/2014717N/A6N/A
12/31/2013698N/A13N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: 3XV's forecast earnings growth (26.3% per year) is above the savings rate (1%).

Earnings vs Market: 3XV's earnings (26.3% per year) are forecast to grow faster than the German market (21.1% per year).

High Growth Earnings: 3XV's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 3XV's revenue (29.4% per year) is forecast to grow faster than the German market (5.7% per year).

High Growth Revenue: 3XV's revenue (29.4% per year) is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: 3XV's Return on Equity is forecast to be low in 3 years time (11.4%).

Discover growth companies

7D

1Y

7D

1Y

7D

1Y